Adherence to Rectal Gel Use Among Mainly Ethnic Minority Young Men Who have Sex with Men During A 3-Month Placebo Gel Trial: Implications for Microbicide Research

被引:14
作者
Carballo-Dieguez, Alex [1 ]
Giguere, Rebecca [1 ]
Dolezal, Curtis [1 ]
Bauermeister, Jose [2 ]
Leu, Cheng-Shiun [1 ]
Valladares, Juan [1 ]
Frasca, Timothy [1 ]
Labbett, Rita [3 ]
Cranston, Ross D. [3 ]
Febo, Irma [4 ]
Mayer, Kenneth [5 ]
McGowan, Ian [6 ]
机构
[1] Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA
[2] Univ Michigan, Sch Publ Hlth Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA
[3] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[4] Univ Puerto Rico, Dept Pediat, Gama Project, San Juan, PR 00936 USA
[5] Fenway Hlth, Fenway Inst, Boston, MA USA
[6] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Ctr Family Planning Res, Magee Womens Res Inst, Pittsburgh, PA USA
关键词
Rectal microbicide; Adherence; Young men who have sex with men; HIV prevention; PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; ACCEPTABILITY; DELIVERY; SAFETY;
D O I
10.1007/s10461-014-0768-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To study adherence to product use prior to a Phase I microbicide trial, we recruited young men who have sex with men (YMSM) with a history of unprotected receptive anal intercourse (RAI) and provided them with 40 rectal applicators containing a placebo gel to use prior to RAI during a 12-week period. Ninety-five YMSM completed the trial. Based on a Computer Assisted Self Interview, 83 participants had receptive anal intercourse (RAI) (Median 12 occasions) using gel on 82.4 % of occasions (SD 26.7; 0-100). Based on an interactive voice response system, 88 participants had RAI (Median 10 occasions) using gel on 87.9 % of occasions (SD 20.0; 20-100). By applicator counts the median gel use was 12. Participants showed high adherence to gel use. Those who did not use the product consistently (n = 40) adduced not having it with them (85 %), forgetting to use it (48 %), not wanting to use it (13 %), partner refusal (10 %) and gel messiness (10 %).
引用
收藏
页码:1726 / 1733
页数:8
相关论文
共 23 条
[1]  
Abdool KarimQ., 2010, Science, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748
[2]   Formulation and Delivery of Microbicides [J].
Agashe, Hrushikesh ;
Hu, Minlu ;
Rohan, Lisa .
CURRENT HIV RESEARCH, 2012, 10 (01) :88-96
[3]  
Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]
[4]   Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men [J].
Carballo-Dieguez, A. ;
Dolezal, C. ;
Bauermeister, J. A. ;
O'Brien, W. ;
Ventuneac, A. ;
Mayer, K. .
SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 (06) :483-487
[5]   Reliability of sexual behavior self-reports in male couples of discordant HIV status [J].
Carballo-Diéguez, A ;
Remien, RH ;
Dolezal, C ;
Wagner, G .
JOURNAL OF SEX RESEARCH, 1999, 36 (02) :152-158
[6]   Rectal microbicide acceptability.: Results of a volume escalation trial [J].
Carballo-Dieguez, Alex ;
Exner, Theresa ;
Dolezal, Curtis ;
Pickard, Robert ;
Lin, Peter ;
Mayer, Kenneth H. .
SEXUALLY TRANSMITTED DISEASES, 2007, 34 (04) :224-229
[7]   "Tell Juliana": Acceptability of the Candidate Microbicide VivaGelA® and Two Placebo Gels Among Ethnically Diverse, Sexually Active Young Women Participating in a Phase 1 Microbicide Study [J].
Carballo-Dieguez, Alex ;
Giguere, Rebecca ;
Dolezal, Curtis ;
Chen, Beatrice A. ;
Kahn, Jessica ;
Zimet, Greg ;
Mabragana, Marina ;
Leu, Cheng-Shiun ;
McGowan, Ian .
AIDS AND BEHAVIOR, 2012, 16 (07) :1761-1774
[8]   Race/ethnic differences in HIV prevalence and risks among adolescent and young adult men who have sex with men [J].
Celentano, DD ;
Sifakis, F ;
Hylton, J ;
Torian, LV ;
Guillin, V ;
Koblin, BA .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2005, 82 (04) :610-621
[9]   Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence [J].
Celum, Connie ;
Baeten, Jared M. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (01) :51-57
[10]  
Centers for Disease Control and Prevention, 2013, CDC HIV TRANSM HIV B